Prestige Consumer Healthcare (PBH) Change in Cash (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Change in Cash of -$56.7 million for Q4 2025, down 8418.47% year-over-year from $682012.6 in Q4 2024, and down 178.16% quarter-over-quarter from -$20.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Change in Cash (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Change in Cash history runs 16 years deep, the most recent figure standing at -$56.7 million for Q4 2025.
- In Q4 2025, Change in Cash fell 8418.47% year-over-year to -$56.7 million; the TTM figure through Dec 2025 stood at $11.5 million (up 190.25% YoY), while the FY2025 annual figure was $51.4 million, up 527.75% from the prior year.
- Change in Cash for Q4 2025 stood at -$56.7 million, down from -$20.4 million in the prior quarter.
- The five-year high for Change in Cash was $131.3 million in Q2 2021, with the low at -$120.8 million in Q3 2021.
- The 5-year median for Change in Cash is $1.4 million (2023), against an average of $13500.0.
- The sharpest annual moves came in 2021 and 2025: Change in Cash soared 456.67% in 2021, then plunged 8418.47% in 2025.
- Prestige Consumer Healthcare's Change in Cash stood at -$21.8 million in 2021, then surged by 301.45% to $43.9 million in 2022, then tumbled by 91.92% to $3.5 million in 2023, then slumped by 118.77% to -$666000.0 in 2024, then slumped by 8418.47% to -$56.7 million in 2025.
- Business Quant data shows PBH's Change in Cash at -$56.7 million in Q4 2025, -$20.4 million in Q3 2025, and $41.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -56.73 Mn |
| Sep 30, 2025 | -20.40 Mn |
| Jun 30, 2025 | 41.62 Mn |
| Mar 31, 2025 | 47.01 Mn |
| Dec 31, 2024 | -666,000.00 |
| Sep 30, 2024 | 17.28 Mn |
| Jun 30, 2024 | -12.21 Mn |
| Mar 31, 2024 | -17.15 Mn |
| Dec 31, 2023 | 3.55 Mn |
| Sep 30, 2023 | 5.49 Mn |
| Jun 30, 2023 | -3.91 Mn |
| Mar 31, 2023 | -27.87 Mn |
| Dec 31, 2022 | 43.92 Mn |
| Sep 30, 2022 | 6.57 Mn |
| Jun 30, 2022 | 8.68 Mn |
| Mar 31, 2022 | 6.17 Mn |
| Dec 31, 2021 | -21.80 Mn |
| Sep 30, 2021 | -120.81 Mn |
| Jun 30, 2021 | 131.32 Mn |
| Mar 31, 2021 | -29.80 Mn |